<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Doseology Sciences, Inc. — News on 6ix</title>
<link>https://6ix.com/company/doseology-sciences-inc</link>
<description>Latest news and press releases for Doseology Sciences, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 30 Mar 2026 11:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/doseology-sciences-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683683c078dffbe2df16967e.webp</url>
<title>Doseology Sciences, Inc.</title>
<link>https://6ix.com/company/doseology-sciences-inc</link>
</image>
<item>
<title>Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-announces-dollar2m-financing-to-accelerate-commercialization-of-oral-stimulant-pouch-platform</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-announces-dollar2m-financing-to-accelerate-commercialization-of-oral-stimulant-pouch-platform</guid>
<pubDate>Mon, 30 Mar 2026 11:00:00 GMT</pubDate>
<description>Doseology Sciences Inc. (CSE: MOOD |OTCQB: DOSEF | FSE: VU70) ("Doseology" or the "Company") a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it has arranged a non-brokered private placement of up to 3,225,806 units (each, a "Unit") at a price of $0.62 per Unit to raise aggregate gross proceeds of up to $2,000,000 (the "Offering").</description>
</item>
<item>
<title>Doseology Uplists to OTCQB as DOSEF, Expanding U.S. Investor Access to the Emerging Oral Stimulant Pouch Category</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-uplists-to-otcqb-as-dosef-expanding-us-investor-access-to-the-emerging-oral-stimulant-pouch-category</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-uplists-to-otcqb-as-dosef-expanding-us-investor-access-to-the-emerging-oral-stimulant-pouch-category</guid>
<pubDate>Wed, 11 Mar 2026 11:00:00 GMT</pubDate>
<description>Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a consumer product innovation company focused on oral stimulant pouch technologies, is pleased to announce that its common shares have commenced trading on the OTCQB® Venture Market in the United States under the symbol DOSEF.</description>
</item>
<item>
<title>Doseology Launches Feed That Brain® Oral Stimulant Pouches in the U.S. Through Direct-to-Consumer Pilot</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-launches-feed-that-brainr-oral-stimulant-pouches-in-the-us-through-direct-to-consumer-pilot-7</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-launches-feed-that-brainr-oral-stimulant-pouches-in-the-us-through-direct-to-consumer-pilot-7</guid>
<pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
<description>Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") today announced the launch of the Feed That Brain® Energy Pouches, marking the Company's first direct-to-consumer pilot program in the United States.</description>
</item>
<item>
<title>Doseology Appoints Larry Latowsky as Executive Chairman of the Board of Directors</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-appoints-larry-latowsky-as-executive-chairman-of-the-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-appoints-larry-latowsky-as-executive-chairman-of-the-board-of-directors</guid>
<pubDate>Fri, 20 Feb 2026 12:00:00 GMT</pubDate>
<description>Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") is pleased to announce the appointment of Larry Latowsky as a director and the Executive Chairman of its Board of Directors, effective February 18, 2026.</description>
</item>
<item>
<title>Doseology Begins Pilot Production of Caffeine-Based Energy Pouches as Feed That Brain® Enters Oral Stimulant Format</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-begins-pilot-production-caffeine-141700276</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-begins-pilot-production-caffeine-141700276</guid>
<pubDate>Wed, 21 Jan 2026 14:17:00 GMT</pubDate>
<description>Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announced the initiation of a pilot production run of non-nicotine, caffeine-based energy pouches under its wholly owned Feed That Brain® brand.</description>
</item>
<item>
<title>The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/compliance-imperative-regulatory-moats-driving-171000432</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/compliance-imperative-regulatory-moats-driving-171000432</guid>
<pubDate>Mon, 19 Jan 2026 17:10:00 GMT</pubDate>
<description>The global consumer healthcare market is hitting a massive structural wall, projected to reach $362.17 billion in 2026[1]. In this high-stakes environment, commercial survival is no longer just about the product; it hinges on precision regulatory execution. Eight key regulatory and compliance pressures[2] are reshaping sector strategy, forcing a capital rotation into a first-mover cohort that includes Doseology Sciences Inc. (CSE: MOOD) (OTCPK:DOSEF) (FSE: VU70), Philip Morris (NYSE: PM), Celsiu</description>
</item>
<item>
<title>Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-files-annual-information-form-160100339</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-files-annual-information-form-160100339</guid>
<pubDate>Fri, 16 Jan 2026 16:01:00 GMT</pubDate>
<description>Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announced that it has filed its Annual Information Form ("AIF"), a key Canadian public-company disclosure document, for the fiscal year ended June 30, 2025 on SEDAR+.</description>
</item>
<item>
<title>Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-engages-mckinney-regulatory-science-120000308</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-engages-mckinney-regulatory-science-120000308</guid>
<pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate>
<description>Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven consumer products, today announced a strategic partnership with McKinney Regulatory Science Advisors ("McKinney"), a premier FDA regulatory consulting firm specializing in nicotine and reduced-risk consumer products, to spearhead its regulatory submission strategy and solidify its commitment to scientific leadership in the oral pouch technology space.</description>
</item>
<item>
<title>Doseology Announces Launch of Corporate Communications Program</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-announces-launch-corporate-communications-120000194</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-announces-launch-corporate-communications-120000194</guid>
<pubDate>Mon, 01 Dec 2025 12:00:00 GMT</pubDate>
<description>KELOWNA, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70)(“Doseology” or the “Company”) is pleased to announce the launch of its Investor Communications Initiative, designed to strengthen disclosure practices, expand investor engagement, and support the Company’s long-term commercial and capital-markets strategy. The program includes a three (3) month engagement with Guerilla Capital, with an option to renew, along with a one (1) y</description>
</item>
<item>
<title>Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc.</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-completes-extensive-north-american-090000408</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-completes-extensive-north-american-090000408</guid>
<pubDate>Thu, 13 Nov 2025 09:00:00 GMT</pubDate>
<description>KELOWNA, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70) (“Doseology” or the “Company”), an innovator in precision-formulated oral stimulants, is pleased to announce that its wholly owned Florida subsidiary, Doseology USA Inc., has executed a confidential manufacturing agreement with a leading North American production partner. This milestone represents a step in Doseology’s operational evolution—establishing the commercial infras</description>
</item>
<item>
<title>Doseology Completes Acquisition of Feed That Brain™</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-completes-acquisition-feed-brain-110000947</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-completes-acquisition-feed-brain-110000947</guid>
<pubDate>Wed, 27 Aug 2025 11:00:00 GMT</pubDate>
<description>Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company"), an innovator in precision-formulated oral stimulants, is pleased to announce that, further to its news release of August 19, 2025, it has closed the acquisition of the "Feed That Brain" division operated by Joseph Mimran & Associates Inc. (the "Vendor") and has completed the issuance to the Vendor of 175,000 common shares (each a "Share") at a deemed price of $1.00 per Share satisfying the first payment</description>
</item>
<item>
<title>Doseology Acquires Feed That Brain™ and Appoints Joseph Mimran as Strategic Advisor</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-acquires-feed-brain-appoints-110000730</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-acquires-feed-brain-appoints-110000730</guid>
<pubDate>Tue, 19 Aug 2025 11:00:00 GMT</pubDate>
<description>Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company"), an innovator in precision-formulated oral stimulants, is pleased to announce that it has entered into an asset purchase and sale agreement (the "Asset Purchase Agreement") to acquire the 'Feed That Brain' division (the "FTB Assets") operated by Joseph Mimran & Associates Inc. (the "Vendor") for aggregate consideration of $400,000 (the "Purchase Price") (the "Transaction").</description>
</item>
<item>
<title>CSE Bulletin: Consolidation - Doseology Sciences Inc. (MOOD)</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/cse-bulletin-consolidation-doseology-sciences-inc-mood</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/cse-bulletin-consolidation-doseology-sciences-inc-mood</guid>
<pubDate>Tue, 13 Feb 2024 16:14:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - Le 13 f&#xE9;vrier/February 2024) - Doseology Sciences Inc. h...</description>
</item>
<item>
<title>Doseology Grows Canadian Retail Sales with Loblaw Companies</title>
<link>https://6ix.com/company/doseology-sciences-inc/news/doseology-grows-canadian-retail-sales-with-loblaw-companies</link>
<guid isPermaLink="true">https://6ix.com/company/doseology-sciences-inc/news/doseology-grows-canadian-retail-sales-with-loblaw-companies</guid>
<pubDate>Thu, 28 Sep 2023 11:30:00 GMT</pubDate>
<description>(TheNewswire) Kelowna, British Columbia &#x2013; TheNewswire - Sept. 28, 2023 &#x20...</description>
</item>
</channel>
</rss>